Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: A multicenter randomized trial

Journal of the National Cancer Institute

Volumn 93, Issue 1, 2001, Pages 31-38

  García Carbonero, Rocio ^a   Mayordomo, Joś I ^b   Tornamira, María V ^a   López Brea, Marta ^c   Rueda, Antonio ^d   Guillem, Vicente ^e   Arcediano, Alberto ^a   Yubero, Alfonso ^b   Ribera, Fernando ^c   Gómez, Carlos ^a   Trés, Alejandro ^b   Pérez Gracia, José L ^a   Lumbreras, Carlos ^a   Hornedo, Javier ^a   Cortés Funes, Hernan ^a   Paz Ares, Luis ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d Hospital Clinico   (Spain)

^e INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFTAZIDIME; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; COMORBIDITY; COMPLICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST OF ILLNESS; DISEASE COURSE; DRUG COST; DRUG EFFICACY; FEBRILE NEUTROPENIA; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SOLID TUMOR;

EID: 0035798795     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.1.31     Document Type: Article

References (29)

1. Infections in patients with acute leukemia and lymphoma
2. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
3. Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells
4. The colony stimulating factors. Discovery, development, and clinical applications
5. Recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines
6. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
7. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial
8. Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: A double-blind, placebo-controlled study in children
9. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors
10. Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor Escherichia coli-derived in cancer patients with fever and neutropenia
11. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia
12. Granulocyte colony-stimulating factor in established febrile neutropenia: A randomized study of pediatric patients
13. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation
14. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule
15. Performance status assessment in cancer patients. An inter-observer variability study
16. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: A prospective, randomized clinical trial
17. A network of algorithm for performing Fisher's exact test in R cross C contingency tables
18. Regression models and life table
19. Update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. American Society of Clinical Oncology
20. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: Implications for discontinuation of antibiotics and early discharge from the hospital
21. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trial
22. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy
23. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy
24. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
25. Economic evaluation of management strategies for low-risk febrile neutropenia cancer patients